Smart Nanoassembly Enabling Activatable NIR Fluorescence and ROS Generation with Enhanced Tumor Penetration for Imaging‐Guided Photodynamic Therapy

Abstract Fluorescence imaging‐guided photodynamic therapy (FIG‐PDT) holds promise for cancer treatment, yet challenges persist in poor imaging quality, phototoxicity, and insufficient anti‐tumor effect. Herein, a novel nanoplatform, LipoHPM, designed to address these challenges, is reported. This approach employs an acid‐sensitive amine linker to connect a biotin‐modified hydrophilic polymer ( Biotin PEG) with a new hydrophobic photosensitizer (MBA), forming OFF‐state Biotin P EG‐ M BA (PM) micelles via an aggregation‐caused quenching (ACQ) effect. These micelles are then co‐loaded with the tumor penetration enhancer hydralazine ( H DZ) into pH‐sensitive liposomes (Lipo HPM ). Leveraging the ACQ effect, LipoHPM is silent in both fluorescence and reactive oxygen species (ROS) generation during blood circulation but restores both properties upon disassembly. Following intravenous injection in tumor‐bearing mice, LipoHPM actively targets tumor cells overexpressing biotin‐receptors, contributing to enhanced tumor accumulation. Upon cellular internalization, LipoHPM disassembles within lysosomes, releasing HDZ to enhance tumor penetration and inhibit tumor metastasis. Concurrently, the micelles activate fluorescence for tumor imaging and boost the production of both type‐I and type‐II ROS for tumor eradication. Therefore, the smart LipoHPM synergistically integrates near‐infrared emission, activatable tumor imaging, robust ROS generation, efficient anti‐tumor and anti‐metastasis activity, successfully overcoming limitations of conventional photosensitizers and establishing itself as a promising nanoplatform for potent FIG‐PDT applications.